Quolet Industries is a privately-held clinical-stage biopharmaceutical company, dedicated to meeting a distinctive market demand for high-dose cannabidiol (CBD) drug products designed to mitigate liver toxicity. Our global biotech startup is at the forefront of addressing this crucial need within rapidly expanding medicinal cannabis industry, which has traditionally been restricted to low-dose CBD formulations. We are committe...
Quolet Industries is a privately-held clinical-stage biopharmaceutical company, dedicated to meeting a distinctive market demand for high-dose cannabidiol (CBD) drug products designed to mitigate liver toxicity. Our global biotech startup is at the forefront of addressing this crucial need within rapidly expanding medicinal cannabis industry, which has traditionally been restricted to low-dose CBD formulations. We are committed to researching and exploring new treatment options for patients who could benefit from CBD, with a focus on developing innovative solutions that offer higher doses of CBD while minimizing the risk of liver toxicity.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.